Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02626455
Title	Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) (CHRONOS-4)
Acronym	CHRONOS-4
Recruitment	Terminated
Gender	both
Phase	Phase III
Variant Requirements	No
Sponsors	Bayer
Indications	follicular lymphoma marginal zone lymphoma chronic lymphocytic leukemia/small lymphocytic lymphoma lymphoplasmacytic lymphoma
Therapies	Vincristine Sulfate Prednisone Aldoxorubicin + Cyclophosphamide + Prednisone + Rituximab + Vincristine Sulfate Copanlisib Bendamustine + Rituximab Rituximab
Age Groups:	adult
Covered Countries	USA \| TUR \| SVK \| ROU \| POL \| ITA \| ISR \| IRL \| HUN \| GRC \| GBR \| FRA \| FIN \| ESP \| DNK \| DEU \| CZE \| CAN \| BRA \| BGR \| BEL \| AUS